Literature DB >> 17598978

Use of desmopressin as an alternative to corticotropin-releasing hormone during inferior petrosal sinus sampling in a child with Cushing's disease.

M H Gannagé-Yared1, S Slaba, T Rizk, R-M Chidiac Wehbe.   

Abstract

Cushing's syndrome (CS) is rare in children. Information on bilateral inferior petrosal sinus sampling (BIPSS) in children with CS is limited. In the procedure CRH is always used to stimulate ACTH values. In addition, growth failure is the main complication of pediatric CS, mainly due to a profound GH suppression that persists for a few months after cure of the disease. Early treatment with recombinant GH after CS cure may partly reverse this phenomenon. We report herein a case of Cushing's disease (CD) in a 7-yr-old child, presenting with severe growth failure. No pituitary adenoma was shown on magnetic resonance imaging and a BIPSS using desmopressin allowed the identification of a central to peripheral (C/P) gradient; however transphenoidal surgery (TSS) did not cure the disease thus requiring the performance of bilateral adrenalectomy. After cure of the disease, a partial catch up of the growth delay occurred without any GH treatment. Our case reinforces the fact that BIPSS can be performed safely in very young children with CD. It also suggests for the first time that the use of desmopressin during the procedure gives the same information as CRH, as well as confirming the fact that the success of TSS is poor in very young children. Finally, it suggests that growth failure in children with CS can be partially reversed after surgical cure of the disease without any GH treatment and that the high IGF-I observed during corticosteroid replacement therapy is due to a state of IGF-I resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17598978     DOI: 10.1007/bf03346323

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

Review 1.  Cushing's syndrome in children and adolescents: current diagnostic and therapeutic strategies.

Authors:  M A Magiakou; G P Chrousos
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

Review 2.  Growth hormone axis in cushing's syndrome.

Authors:  B L Wajchenberg; B Liberman; D Giannella Neto; M Y Morozimato; M Semer; L O Bracco; L R Salgado; M Knoepfelmacher; M H Borges; A C Pinto; C E Kater; A M Lengyel
Journal:  Horm Res       Date:  1996

3.  Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling.

Authors:  E H Oldfield; G P Chrousos; H M Schulte; M Schaaf; P E McKeever; A G Krudy; G B Cutler; D L Loriaux; J L Doppman
Journal:  N Engl J Med       Date:  1985-01-10       Impact factor: 91.245

Review 4.  Growth in disorders of adrenal hyperfunction.

Authors:  M O Savage; S Scommegna; P V Carroll; J T F Ho; J P Monson; G M Besser; A B Grossman
Journal:  Horm Res       Date:  2002

5.  Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.

Authors:  Helen L Storr; Farhad Afshar; Matthew Matson; Ian Sabin; Kate M Davies; Jane Evanson; P Nicholas Plowman; G Michael Besser; John P Monson; Ashley B Grossman; Martin O Savage
Journal:  Eur J Endocrinol       Date:  2005-06       Impact factor: 6.664

6.  Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.

Authors:  M A Magiakou; G Mastorakos; M T Gomez; S R Rose; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1994-01       Impact factor: 5.958

7.  Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome.

Authors:  Marinella Tzanela; Niki Karavitaki; Christiana Stylianidou; Stylianos Tsagarakis; Nikos C Thalassinos
Journal:  Clin Endocrinol (Oxf)       Date:  2004-03       Impact factor: 3.478

8.  Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion.

Authors:  P V Carroll; J P Monson; A B Grossman; G M Besser; P N Plowman; F Afshar; M O Savage
Journal:  Clin Endocrinol (Oxf)       Date:  2004-02       Impact factor: 3.478

9.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

10.  Pediatric pituitary adenomas.

Authors:  T Mindermann; C B Wilson
Journal:  Neurosurgery       Date:  1995-02       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.